{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:28:38Z","timestamp":1789752518795,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jacl.2017.11.009","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T09:55:24Z","timestamp":1512640524000},"page":"375-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Treatment goal attainment in children with familial hypercholesterolemia: A cohort study of\u00a0302 children in Norway"],"prefix":"10.1016","volume":"12","author":[{"given":"Martin P.","family":"Bogsrud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4034-2243","authenticated-orcid":false,"given":"Gisle","family":"Langslet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1485-9580","authenticated-orcid":false,"given":"Cecilie","family":"Wium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Svilaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten B.","family":"Holven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2017.11.009_bib1","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2017.11.009_bib2","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/eurheartj\/ehv602","article-title":"Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death","volume":"37","author":"Krogh","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2017.11.009_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/2047487316676135","article-title":"Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013","volume":"24","author":"Mundal","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacl.2017.11.009_bib4","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1177\/2047487316666371","article-title":"Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study","volume":"23","author":"Mundal","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacl.2017.11.009_bib5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/CIRCRESAHA.114.301430","article-title":"Carotid intima-media thickness in children with familial hypercholesterolemia","volume":"114","author":"Kusters","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jacl.2017.11.009_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.atherosclerosis.2014.05.917","article-title":"Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review","volume":"235","author":"Narverud","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2017.11.009_bib7","doi-asserted-by":"crossref","first-page":"e001236","DOI":"10.1161\/JAHA.114.001236","article-title":"Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010","volume":"3","author":"Mundal","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacl.2017.11.009_bib8","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.clinthera.2016.05.006","article-title":"Cardiovascular Disease Risk Associated With Familial Hypercholesterolemia: a Systematic Review of the Literature","volume":"38","author":"Wong","year":"2016","journal-title":"Clin Ther"},{"key":"10.1016\/j.jacl.2017.11.009_bib9","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","article-title":"Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2017.11.009_bib10","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/jama.2014.8892","article-title":"Ten-year follow-up after initiation of statin therapy in children with familial hypercholesterolemia","volume":"312","author":"Kusters","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2017.11.009_bib11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jacc.2015.11.021","article-title":"Statin initiation during childhood in patients with familial hypercholesterolemia: consequences for cardiovascular risk","volume":"67","author":"Braamskamp","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jacl.2017.11.009_bib12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1161\/CIRCULATIONAHA.116.025158","article-title":"Effect of rosuvastatin on carotid intima-media thickness in children with heterozygous familial hypercholesterolemia: the CHARON study","volume":"136","author":"Braamskamp","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2017.11.009_bib13","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2017.11.009_bib14","first-page":"60","article-title":"Reproducibility and validity of a short food questionnaire for the assessment of dietary habits","volume":"12","author":"Svilaas","year":"2002","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jacl.2017.11.009_bib15","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jacl.2015.08.008","article-title":"Long-term follow-up of young adults with familial hypercholesterolemia after participation in clinical trials during childhood","volume":"9","author":"Langslet","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2017.11.009_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2003.11.010","article-title":"Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia","volume":"173","author":"Civeira","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2017.11.009_bib17","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1161\/CIRCULATIONAHA.107.181946","volume":"115","author":"McCrindle","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2017.11.009_bib18","first-page":"CD006401","article-title":"Statins for children with familial hypercholesterolemia","volume":"7","author":"Vuorio","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacl.2017.11.009_bib19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jacl.2015.07.011","article-title":"Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: results from the CHARON study","volume":"9","author":"Braamskamp","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2017.11.009_bib20","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jacl.2016.05.010","article-title":"A 3-year study of atorvastatin in children and adolescents with heterozygous familial hypercholesterolemia","volume":"10","author":"Langslet","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2017.11.009_bib21","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jpeds.2015.05.006","article-title":"Efficacy and safety of pitavastatin in children and adolescents at high future cardiovascular risk","volume":"167","author":"Braamskamp","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.jacl.2017.11.009_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/archdischild-2015-308570","article-title":"The UK paediatric familial hypercholesterolaemia register: preliminary data","volume":"102","author":"Ramaswami","year":"2017","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jacl.2017.11.009_bib23","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.recesp.2016.10.012","article-title":"Attainment of LDL cholesterol treatment goals in children and adolescents with familial hypercholesterolemia. The SAFEHEART follow-up registry","volume":"70","author":"Saltijeral","year":"2017","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.jacl.2017.11.009_bib24","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1515\/CCLM.2008.135","article-title":"Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing","volume":"46","author":"Starr","year":"2008","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jacl.2017.11.009_bib25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.atherosclerosis.2011.06.016","article-title":"Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization","volume":"218","author":"Descamps","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2017.11.009_bib26","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1602777","article-title":"Child-parent familial hypercholesterolemia screening in primary care","volume":"375","author":"Wald","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2017.11.009_bib27","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2017.11.009_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2016.07.913","article-title":"Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemia","volume":"252","author":"Torvik","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2017.11.009_bib29","article-title":"Familial hypercholesterolaemia: identification and management","volume":"Vol. 2017","year":"2008"},{"issue":"Suppl 5","key":"10.1016\/j.jacl.2017.11.009_bib30","first-page":"S213","article-title":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report","volume":"128","year":"2011","journal-title":"Pediatrics"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287417305342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287417305342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T07:28:58Z","timestamp":1535182138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287417305342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1933287417305342"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2017.11.009","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment goal attainment in children with familial hypercholesterolemia: A cohort study of\u00a0302 children in Norway","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2017.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}